Delivery Order SPE2D021DA002-SPE2D325F284L
Award Date 8/4/25
Potential Completion Date 8/7/25
Potential Value $9.1K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 6, 2025, for 1,440 units of HAVRIX 1,440 Unit/ML syringes with a ceiling value of $2,268.40. This delivery order, issued without a set-aside designation, is part of the company's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499.9 million through November 2026. The contract is...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 27, 2025, for HAVRIX 720 Unit/0.5 ML syringes valued at $2,168.80. This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 28, 2025, with performance to be completed at the awardee's Park Ridge, Illinois location. HAVRIX is a...
- The Defense Logistics Agency (DLA) Medical Supply Chain division awarded a delivery order valued at $2,268.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 10, 2025. The delivery order calls for 1,440 units per milliliter of Havrix, a hepatitis A vaccine, to be delivered by September 15, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- <p>This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of 1,440 units of HAVRIX vaccine in 1 ml syringes. The potential value of this firm fixed price contract is $2,033.40. Performance will occur in Park Ridge, Illinois, with delivery required no later than January 25, 2023. No set-aside provisions were applied to this award in support of the Defense Logistics Agency's medical supply chain responsibilities.</p>
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 on July 24, 2025, for the supply of Twinrix vaccine syringes. This firm fixed-price delivery order, which is expected to be completed by July 29, 2025, was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. The award represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc. was awarded a four hundred six dollar firm fixed price delivery order for 1,440 unit/ml syringes of HAVRIX vaccine. The contract has no set-aside designation and is being awarded by the Defense Logistics Agency to fulfill their vaccine requirements. Performance will occur in Park Ridge, Illinois with delivery by January 6, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the Department of Defense, this contract will help the...
- The U.S. Defense Logistics Agency awarded a $1,591.88 firm fixed-price purchase order to DMS Pharmaceutical Group Inc. for Hepatitis A Virus vaccine on September 15, 2025, with an ultimate completion date of October 15, 2025. The order will be delivered to Park Ridge, Illinois, where the vendor is based. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected without a set-aside designation. The company maintains a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at two thousand four hundred forty dollars and eight cents to DMS Pharmaceutical Group Inc. to supply one thousand four hundred forty units of HAVRIX, a hepatitis A vaccine presented as one milliliter pre-filled syringes. Performance will take place in Park Ridge, Illinois over a one day period from February 16 to 17, 2023. The DLA procures medical supplies and equipment to support Department of Defense programs....
- The Defense Logistics Agency awarded a $1,220 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 1,440 units of HAVRIX vaccine in pre-filled syringes. The vaccine will be delivered to a location in Park Ridge, Illinois by February 13, 2023 to support the Department of Defense's immunization programs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to fulfill vaccine...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 on July 24, 2025, for the supply of Twinrix vaccine syringes. The order, with an ultimate completion date of July 29, 2025, was issued under a firm fixed-price contract type with no set-aside designation. The place of performance is Park Ridge, Illinois, and the award was funded by the Defense Logistics Agency's Medical Supply Chain...